Header Logo

Connection

RONALD RAUCH to Antineoplastic Agents, Immunological

Back to Details
This is a "connection" page, showing publications RONALD RAUCH has written about Antineoplastic Agents, Immunological.
RONALD RAUCH
Connection Strength
0.199
Antineoplastic Agents, Immunological
  1. Real-World Immune-Related Adverse Events in Patients With Early Triple-Negative Breast Cancer Who Received Pembrolizumab. JCO Oncol Pract. 2025 Sep; 21(9):1265-1273.
    View in: PubMed
    Score: 0.199
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.